Literature DB >> 7637037

Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis.

S A Stohlman1, D R Hinton, D Cua, E Dimacali, J Sensintaffar, F M Hofman, S M Tahara, Q Yao.   

Abstract

Neutralizing anti-tumor necrosis factor alpha (TNF-alpha) antibody treatment of mice infected with the neurotropic JHMV strain of mouse hepatitis virus showed no reduction of either virus-induced encephalomyelitis or central nervous system demyelination. TNF-alpha-positive cells were present in the central nervous system during infection; however, TNF-alpha could not be colocalized with JHMV-infected cells. In vitro, TNF-alpha mRNA rapidly accumulated following JHMV infection; however, no TNF-alpha was secreted because of inhibition of translation. Both live and UV-inactivated virus inhibited TNF-alpha secretion induced by lipopolysaccharide. These data show that TNF-alpha is not secreted from infected cells and indicate that if contributes to either JHMV-induced acute encephalomyelitis nor primary demyelination.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637037      PMCID: PMC189470     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.

Authors:  F Powrie; S Menon; R L Coffman
Journal:  Eur J Immunol       Date:  1993-11       Impact factor: 5.532

2.  TCR cross-linking induces CTL death via internal action of TNF.

Authors:  J Wang; S A Stohlman; G Dennert
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

3.  Modulation of cellular macromolecular synthesis by coronavirus: implication for pathogenesis.

Authors:  S Kyuwa; M Cohen; G Nelson; S M Tahara; S A Stohlman
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines.

Authors:  V Balasingam; T Tejada-Berges; E Wright; R Bouckova; V W Yong
Journal:  J Neurosci       Date:  1994-02       Impact factor: 6.167

5.  Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen.

Authors:  S Brocke; A Gaur; C Piercy; A Gautam; K Gijbels; C G Fathman; L Steinman
Journal:  Nature       Date:  1993-10-14       Impact factor: 49.962

6.  Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo.

Authors:  B D Pearce; M V Hobbs; T S McGraw; M J Buchmeier
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Failure to inhibit endotoxin-induced uveitis with antibodies that neutralize tumor necrosis factor.

Authors:  J T Rosenbaum; R S Boney
Journal:  Reg Immunol       Date:  1993 Sep-Oct

8.  Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus.

Authors:  B L Haagmans; F S Stals; P H van der Meide; C A Bruggeman; M C Horzinek; V E Schijns
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

Review 9.  Pathogenesis of virus-induced demyelination.

Authors:  J K Fazakerley; M J Buchmeier
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

10.  Coronavirus translational regulation: leader affects mRNA efficiency.

Authors:  S M Tahara; T A Dietlin; C C Bergmann; G W Nelson; S Kyuwa; R P Anthony; S A Stohlman
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

View more
  24 in total

1.  Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA.

Authors:  H P Li; X Zhang; R Duncan; L Comai; M M Lai
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Immune responses of the domestic fowl to Dermanyssus gallinae under laboratory conditions.

Authors:  David W J Harrington; Karen Robinson; Olivier A E Sparagano
Journal:  Parasitol Res       Date:  2010-03-24       Impact factor: 2.289

3.  Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis.

Authors:  Timothy W Phares; Stephen A Stohlman; David R Hinton; Roscoe Atkinson; Cornelia C Bergmann
Journal:  J Immunol       Date:  2010-09-27       Impact factor: 5.422

4.  CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus.

Authors:  Stephen A Stohlman; David R Hinton; Beatriz Parra; Roscoe Atkinson; Cornelia C Bergmann
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

5.  Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis.

Authors:  M T Lin; S A Stohlman; D R Hinton
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 6.  Murine coronavirus infection: a paradigm for virus-induced demyelinating disease.

Authors:  T E Lane; M J Buchmeier
Journal:  Trends Microbiol       Date:  1997-01       Impact factor: 17.079

7.  Coronavirus-induced demyelination occurs in the absence of inducible nitric oxide synthase.

Authors:  G F Wu; L Pewe; S Perlman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Regulation of proinflammatory cytokine expression in primary mouse astrocytes by coronavirus infection.

Authors:  Dongdong Yu; Hongqing Zhu; Yin Liu; Jianzhong Cao; Xuming Zhang
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

9.  Generation of a protective T-cell response following coronavirus infection of the central nervous system is not dependent on IL-12/23 signaling.

Authors:  Katherine S Held; William G Glass; Yevgeniya I Orlovsky; Kimberly A Shamberger; Ted D Petley; Patrick J Branigan; Jill M Carton; Heena S Beck; Mark R Cunningham; Jacqueline M Benson; Thomas E Lane
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

10.  CD4 T-cell-mediated demyelination is increased in the absence of gamma interferon in mice infected with mouse hepatitis virus.

Authors:  Lecia Pewe; Jodie Haring; Stanley Perlman
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.